Microarray-based prenatal diagnosis for the identification of fetal chromosome abnormalities

Expert Review of Molecular Diagnostics

Volumn 13, Issue 6, 2013, Pages 601-611

  Shaffer, Lisa G ^a   Rosenfeld, Jill A ^b  

^a Paw Print Genetics Genetic Veterinary Sciences Inc   (United States)

^b PERKINELMER INC   (United States)

Author keywords

chromosome analysis; comparative genomic hybridization; copy number variant; karyotype; microarray; prenatal diagnosis; single nucleotide polymorphism

Indexed keywords

DNA;

CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLEFT LIP; CLEFT PALATE; COMPARATIVE GENOMIC HYBRIDIZATION; GENE CONVERSION; GENETIC COUNSELING; GENOME; HETEROZYGOSITY LOSS; HOLOPROSENCEPHALY; HOMOZYGOSITY; HUMAN; MICROARRAY ANALYSIS; MOSAICISM; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETON MALFORMATION;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FETUS; GENOME, HUMAN; HUMANS; KARYOTYPING; MICROARRAY ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84881096493     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.811912     Document Type: Review

References (91)

1. Benn PA, Egan JF, Fang M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet. Gynecol. 103(6), 1255-1260 (2004
2. Nicolaides KH, Snijders RJ, Gosden CM, Berry C, Campbell S. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340(8821), 704-707 (1992
3. Drugan A, Johnson MP, Evans MI. Ultrasound screening for fetal chromosome anomalies. Am. J. Med. Genet. 90(2), 98-107 (2000
4. Daniel A, Athayde N, Ogle R et al. Prospective ranking of the sonographic markers for aneuploidy: Data of 2143 prenatal cytogenetic diagnoses referred for abnormalities on ultrasound. Aust. N. Z. J. Obstet. Gynaecol. 43(1), 16-26 (2003
5. Staebler M, Donner C, Van Regemorter N et al. Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound? Prenat. Diagn. 25(7), 567-573 (2005
6. Tseng JJ, Chou MM, Lo FC, Lai HY, Chen MH, Ho ES. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: Experience during 1995-2004. Taiwan. J. Obstet. Gynecol. 45(1), 39-41 (2006
7. Volpe P, Marasini M, Caruso G et al. 22q11 deletions in fetuses with malformations of the outflow tracts or interruption of the aortic arch: Impact of additional ultrasound signs. Prenat. Diagn. 23(9), 752-757 (2003
8. Liu T, Liu Q, Wang YX et al. Use of amniocytes for prenatal diagnosis of 22q11.2 microdeletion syndrome: A feasibility study. Chin. Med. J. 123(4), 438-442 (2010
9. Willis AS, van den Veyver I, Eng CM. Multiplex ligation-dependent probe amplification (MLPA) and prenatal diagnosis. Prenat. Diagn. 32(4), 315-320 (2012
10. Shaffer LG, Beaudet AL, Brothman AR et al.; Working Group of the Laboratory Quality Assurance Committee of the American College of Medical Genetics. Microarray analysis for constitutional cytogenetic abnormalities. Genet. Med. 9(9), 654-662 (2007
11. Kearney HM, South ST, Wolff DJ, Lamb A, Hamosh A, Rao KW; Working Group of the American College of Medical Genetics. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet. Med. 13(7), 676-679 (2011
12. Kearney HM, Kearney JB, Conlin LK. Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: Consanguinity, uniparental disomy, and recessive single-gene mutations. Clin. Lab. Med. 31(4), 595-613, ix (2011
13. Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: An overview. Am. J. Med. Genet. C. Semin Med. Genet. 154C(3), 329-334 (2010
14. Shaffer LG. Risk estimates for uniparental disomy following prenatal detection of a nonhomologous Robertsonian translocation. Prenat. Diagn. 26(4), 303-307 (2006
15. Ballif BC, Kashork CD, Saleki R et al. Detecting sex chromosome anomalies and common triploidies in products of conception by array-based comparative genomic hybridization. Prenat. Diagn. 26(4), 333-339 (2006
16. Shaffer LG, Kashork CD, Saleki R et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J. Pediatr. 149(1), 98-102 (2006
17. Miller DT, Adam MP, Aradhya S et al. Consensus statement: Chromosomal microarray is a first-Tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86(5), 749-764 (2010
18. Schaeffer AJ, Chung J, Heretis K, Wong A, Ledbetter DH, Lese Martin C. Comparative genomic hybridization-Array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. Am. J. Hum. Genet. 74(6), 1168-1174 (2004
19. Benkhalifa M, Kasakyan S, Clement P et al. Array comparative genomic hybridization profiling of first-Trimester spontaneous abortions that fail to grow in vitro. Prenat. Diagn. 25(10), 894-900 (2005
20. Le Caignec C, Boceno M, Saugier-Veber P et al. Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J. Med. Genet. 42(2), 121-128 (2005
21. Rickman L, Fiegler H, Shaw-Smith C et al. Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J. Med. Genet. 43(4), 353-361 (2006
22. Shimokawa O, Harada N, Miyake N et al. Array comparative genomic hybridization analysis in first-Trimester spontaneous abortions with 'normal' karyotypes. Am. J. Med. Genet. A 140(18), 1931-1935 (2006
23. Menten B, Swerts K, Delle Chiaie B et al. Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples. BMC Med. Genet. 10, 89 (2009
24. Tyreman M, Abbott KM, Willatt LR et al. High resolution array analysis: Diagnosing pregnancies with abnormal ultrasound findings. J. Med. Genet. 46(8), 531-541 (2009
25. Vialard F, Molina Gomes D, Leroy B et al. Array comparative genomic hybridization in prenatal diagnosis: Another experience. Fetal. Diagn. Ther. 25(2), 277-284 (2009
26. Deshpande M, Harper J, Holloway M, Palmer R, Wang R. Evaluation of array comparative genomic hybridization for genetic analysis of chorionic villus sampling from pregnancy loss in comparison to karyotyping and multiplex ligation-dependent probe amplification. Genet. Test. Mol. Biomarkers 14(3), 421-424 (2010
27. Faas BH, van der Burgt I, Kooper AJ et al. Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis. J. Med. Genet. 47(9), 586-594 (2010
28. Rajcan-Separovic E, Diego-Alvarez D, Robinson WP et al. Identification of copy number variants in miscarriages from couples with idiopathic recurrent pregnancy loss. Hum. Reprod. 25(11), 2913-2922 (2010
29. Rajcan-Separovic E, Qiao Y, Tyson C et al. Genomic changes detected by array CGH in human embryos with developmental defects. Mol. Hum. Reprod. 16(2), 125-134 (2010
30. Valduga M, Philippe C, Bach Segura P et al. A retrospective study by oligonucleotide array-CGH analysis in 50 fetuses with multiple malformations. Prenat. Diagn. 30(4), 333-341 (2010
31. Sahoo T, Cheung SW, Ward P et al. Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization. Genet. Med. 8(11), 719-727 (2006
32. Shaffer LG, Coppinger J, Alliman S et al. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat. Diagn. 28(9), 789-795 (2008
33. Van den Veyver IB, Patel A, Shaw CA et al. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat. Diagn. 29(1), 29-39 (2009
34. Coppinger J, Alliman S, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG. Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray. Prenat. Diagn. 29(12), 1156-1166 (2009
35. Kleeman L, Bianchi DW, Shaffer LG et al. Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat. Diagn. 29(13), 1213-1217 (2009
36. Maya I, Davidov B, Gershovitz L et al. Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat. Diagn. 30(12-13), 1131-1137 (2010
37. Hillman SC, Pretlove S, Coomarasamy A et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: A systematic review and meta-Analysis. Ultrasound Obstet. Gynecol. 37(1), 6-14 (2011
38. Park SJ, Jung EH, Ryu RS et al. Clinical implementation of whole-genome array CGH as a first-Tier test in 5080 pre and postnatal cases. Mol. Cytogenet. 4, 12 (2011
39. Fiorentino F, Caiazzo F, Napolitano S et al. Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: A prospective study on over 1000 consecutive clinical cases. Prenat. Diagn. 31(13), 1270-1282 (2011
40. D'Amours G, Kibar Z, Mathonnet G et al. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin. Genet. 81(2), 128-141 (2012
41. Breman A, Pursley AN, Hixson P et al. Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature. Prenat. Diagn. 32(4), 351-361 (2012
42. Lee CN, Lin SY, Lin CH, Shih JC, Lin TH, Su YN. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: A cohort study of 3171 pregnancies. BJOG 119(5), 614-625 (2012
43. Armengol L, Nevado J, Serra-Juhé C et al. Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum. Genet. 131(3), 513-523 (2012
44. Shaffer LG, Dabell MP, Fisher AJ et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat. Diagn. 32(10), 976-985 (2012
45. Wapner RJ, Martin CL, Levy B et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med. 367(23), 2175-2184 (2012
46. Fiorentino F, Napoletano S, Caiazzo F et al. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur. J. Hum. Genet. 21(7), 725-730 (2013
47. Srebniak MI, Boter M, Oudesluijs GO et al. Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities. Mol. Cytogenet. 5(1), 14 (2012
48. Yatsenko S, Davis S, Hendrix N et al. Application of chromosomal microarray in the evaluation of abnormal prenatal findings. Clin. Genet. 84(1), 47-54 (2013
49. Scott F, Murphy K, Carey L et al. Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: Results from over 1000 consecutive cases. Ultrasound Obstet. Gynecol. 41(5), 500-507 (2013
50. Schmid M, Stary S, Springer S, Bettelheim D, Husslein P, Streubel B. Prenatal microarray analysis as second-Tier diagnostic test: Single-center prospective study. Ultrasound Obstet. Gynecol. 41(3), 267-273 (2013
51. Rooryck C, Toutain J, Cailley D et al. Prenatal diagnosis using array-CGH: A French experience. Eur. J. Med. Genet. doi:10.1016/j.ejmg.2013.02. 003 (2013) (Epub ahead of print
52. Ganesamoorthy D, Bruno DL, McGillivray G et al Meeting the challenge of interpreting high-resolution single nucleotide polymorphism array data in prenatal diagnosis: Does increased diagnostic power outweigh the dilemma of rare variants? BJOG 120(5), 594-606 (2013
53. Shaffer LG, Rosenfeld JA, Dabell MP et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat. Diagn. 32(10), 986-995 (2012
54. Leung TY, Vogel I, Lau TK et al. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet. Gynecol. 38(3), 314-319 (2011
55. Schou KV, Kirchhoff M, Nygaard U, Jørgensen C, Sundberg K. Increased nuchal translucency with normal karyotype: A follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet. Gynecol. 34(6), 618-622 (2009
56. Schmid M, Stary S, Blaicher W, Gollinger M, Husslein P, Streubel B. Prenatal genetic diagnosis using microarray analysis in fetuses with congenital heart defects. Prenat. Diagn. 32(4), 376-382 (2012
57. Shaffer LG, Dabell MP, Rosenfeld JA et al. Referral patterns for microarray testing in prenatal diagnosis. Prenat. Diagn. 32(4), 344-350 (2012
58. Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet. 19(R2), R176-R187 (2010
59. Vermeesch JR, Balikova I, Schrander-Stumpel C, Fryns JP, Devriendt K. The causality of de novo copy number variants is overestimated. Eur. J. Hum. Genet. 19(11), 1112-1113 (2011
60. Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet. Med. doi:10.1038/gim.2012.164 (2012) (Epub ahead of print
61. Gardner RJM, Sutherland GR, Shaffer LG. Chromosome Abnormalities and Genetic Counseling (4th Edition). Oxford University Press, NY, USA (2012
62. Ballif BC, Rorem EA, Sundin K et al. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am. J. Med. Genet. A 140(24), 2757-2767 (2006
63. Cheung SW, Shaw CA, Scott DA et al. Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am. J. Med. Genet. A 143A(15), 1679-1686 (2007
64. Neill NJ, Torchia BS, Bejjani BA, Shaffer LG, Ballif BC. Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH. Mol. Cytogenet. 3, 11 (2010
65. Scott SA, Cohen N, Brandt T, Toruner G, Desnick RJ, Edelmann L. Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. Genet. Med. 12(2), 85-92 (2010
66. Lamb AN, Rosenfeld JA, Coppinger J et al. Defining the impact of maternal cell contamination on the interpretation of prenatal microarray analysis. Genet. Med. 14(11), 914-921 (2012
67. Valli R, Marletta C, Pressato B et al. Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells. Mol. Cytogenet. 4, 13 (2011
68. Nagan N, Faulkner NE, Curtis C, Schrijver I; MCC Guidelines Working Group of the Association for Molecular Pathology Clinical Practice Committee. Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology. J. Mol. Diagn. 13(1), 7-11 (2011
69. Li D, Liao C. Incidental discovery of nonpaternity during prenatal testing of genetic disease. Fetal. Diagn. Ther. 24(1), 39-41 (2008
70. McGillivray G, Rosenfeld JA, McKinlay Gardner RJ, Gillam LH. Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenat. Diagn. 32(4), 389-395 (2012
71. Wapner RJ, Driscoll DA, Simpson JL. Integration of microarray technology into prenatal diagnosis: Counselling issues generated during the NICHD clinical trial. Prenat. Diagn. 32(4), 396-400 (2012
72. Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet. Med. 15(2), 139-145 (2013
73. De Gregori M, Ciccone R, Magini P et al. Cryptic deletions are a common finding in 'balanced' reciprocal and complex chromosome rearrangements: A study of 59 patients. J. Med. Genet. 44(12), 750-762 (2007
74. Baptista J, Mercer C, Prigmore E et al. Breakpoint mapping and array CGH in translocations: Comparison of a phenotypically normal and an abnormal cohort. Am. J. Hum. Genet. 82(4), 927-936 (2008
75. Talkowski ME, Ordulu Z, Pillalamarri V et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N. Engl. J. Med. 367(23), 2226-2232 (2012
76. Bi W, Borgan C, Pursley AN et al. Comparison of chromosome analysis and chromosomal microarray analysis: What is the value of chromosome analysis in today's genomic array era? Genet. Med. 15(6), 450-457 (2013
77. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. Non-invasive prenatal measurement of the fetal genome. Nature 487(7407), 320-324 (2012
78. Kitzman JO, Snyder MW, Ventura M et al. Noninvasive whole-genome sequencing of a human fetus. Sci. Transl. Med. 4(137), 137 (2012
79. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MELISSA Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet. Gynecol. 119(5), 890-901 (2012
80. Chiu RW, Akolekar R, Zheng YW et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342, c7401 (2011
81. Ehrich M, Deciu C, Zwiefelhofer T et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am. J. Obstet. Gynecol. 204(3), 205.e1-205.11 (2011
82. Sparks AB, Wang ET, Struble CA et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat. Diagn. 32(1), 3-9 (2012
83. Palomaki GE, Kloza EM, Lambert-Messerlian GM et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet. Med. 13(11), 913-920 (2011
84. Palomaki GE, Deciu C, Kloza EM et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genet. Med. 14(3), 296-305 (2012
85. Chen EZ, Chiu RW, Sun H et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE 6(7), e21791 (2011
86. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am. J. Hum. Genet. 92(2), 167-176 (2013
87. Pang AW, MacDonald JR, Pinto D et al. Towards a comprehensive structural variation map of an individual human genome. Genome Biol. 11(5), R52 (2010
88. ACOG. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet. Gynecol. 120(6), 1532-1534 (2012
89. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the national society of genetic counselors. J. Genet. Couns. 22(3), 291-295 (2013
90. Gregg AR, Gross SJ, Best RG et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet. Med. 15(5), 395-398 (2013
91. Benn P, Borell A, Chiu R et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. doi:10.1002/ pd.4139 (2013) (Epub ahead of print